Allergy Therapeutics PLC Stock
€0.11
Your prediction
Allergy Therapeutics PLC Stock
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
Cons
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | -5.000% | 2.703% | 31.792% | 74.046% | 66.423% | -4.202% | -20.557% |
| Beximco Pharmaceuticals Ltd. GDR | - | 4.444% | 4.444% | 13.527% | 12.981% | -21.667% | -44.048% |
| SELLAS Life Sciences Group Inc | 2.860% | 15.067% | 32.769% | 101.166% | 83.422% | -27.601% | -75.000% |
| Eledon Pharmaceuticals Inc. | 13.850% | 11.278% | -22.105% | -67.111% | -63.725% | -36.207% | -90.976% |
News
Can ASTS Stock Beat the Market in 2026?
AST SpaceMobile (NASDAQ: ASTS) was a bad investment from 2020 to the start of 2024. The stock woefully underperformed the S&P 500 during that stretch and went from $20 per share to $2 per share
3 Absurdly Cheap Dividend Stocks to Buy for Less Than $100
Buying dividend stocks at low prices can have two positive benefits. The first is that if you're buying low, the yield can be higher than normal. It can provide you with some high dividend income
Great News for AST SpaceMobile Investors
AST SpaceMobile (NASDAQ: ASTS) is on a mission to eliminate dead zones through direct-to-smartphone satellite technology. Its partnerships with telecom giants like AT&T and Vodafone and its massive


